Shand Harshita, Patra Soumendu, Chandrasekhar Bavya, Kulkarni Sharvari, Madhavan Thirumurthy, Ghorai Suvankar
Department of Microbiology, Raiganj University, Uttar Dinajpur, Raiganj, West Bengal India.
Computational Biology Laboratory, Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Chengalpattu District, Kattankulathur 603203, Potheri, Tamilnadu India.
In Silico Pharmacol. 2024 Aug 21;12(2):76. doi: 10.1007/s40203-024-00251-y. eCollection 2024.
In accordance to the American Heart Association (AHA), cardiovascular diseases (CVDs) are the leading cause of death around the globe, causing more than 19.1 million deaths in 2020. Heart-type fatty acid binding protein (H-FABP) is required for the metabolism of fatty acids (FA) inside cardiomyocytes is reported as a biomarker for myocardial damage. As early as one hour after an Acute myocardial infarction (AMI), H-FABP can be used to detect myocardial ischemia. Thus, H-FABP based detection can reduce the burden on the emergency department. A peptide-based detection system can provide point-of-care diagnostics for CVDs. There is a lot of research being done on peptide-based detection, and it has a lot of potential to help with unmet medical diagnostic needs. A twelve (12) amino acid peptide has been discovered using Phage Display Library Screening. The affinity of peptide with H-FABP and other FABPs has been done using molecular docking and ADMET profile has been done. Molecular docking of small peptides against the target protein can play a crucial role in recognizing peptide binding sites and poses. The docking study was done using the HDOCK server and the visualization of the docked complex was done using Pymol and UCSF chimera. The molecular simulation study of three protein-peptide complexes were done which also validated the binding affinity of peptide with the proteins. The RMSD, RMSF and radius of gyration are also analyzed. The results indicate that H-FABP shows higher level of binding interaction with the peptide having bond length ranging from 2.3 to 3.4 Å. The screened peptide is suitable for H-FABP binding and can be used for prognosis purposes in the heart ischemic conditions.
根据美国心脏协会(AHA)的数据,心血管疾病(CVD)是全球主要的死亡原因,2020年导致超过1910万人死亡。心脏型脂肪酸结合蛋白(H-FABP)是心肌细胞内脂肪酸(FA)代谢所必需的,被报道为心肌损伤的生物标志物。早在急性心肌梗死(AMI)发生一小时后,H-FABP就可用于检测心肌缺血。因此,基于H-FABP的检测可以减轻急诊科的负担。基于肽的检测系统可为心血管疾病提供即时诊断。目前正在对基于肽的检测进行大量研究,它在满足未满足的医学诊断需求方面有很大潜力。通过噬菌体展示文库筛选发现了一种十二(12)氨基酸肽。已使用分子对接研究了该肽与H-FABP和其他FABP的亲和力,并完成了其ADMET分析。小肽与目标蛋白的分子对接在识别肽结合位点和构象方面可发挥关键作用。对接研究使用HDOCK服务器进行,对接复合物的可视化使用Pymol和UCSF chimera完成。对三种蛋白质-肽复合物进行了分子模拟研究,也验证了肽与蛋白质的结合亲和力。还分析了均方根偏差(RMSD)、均方根波动(RMSF)和回转半径。结果表明,H-FABP与键长在2.3至3.4 Å范围内的肽表现出更高水平的结合相互作用。筛选出的肽适合与H-FABP结合,可用于心脏缺血状况的预后评估。